Press Releases
September 16, 2020
Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee and vocal advocate for safe, affordable, COVID-19 vaccines and treatments, released the following statement on the report regarding distribution of a COVID-19 vaccine released by the Trump Administration today:
Issues:
September 14, 2020
Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, called on CMS to publicly release the final report of the Coronavirus Commission on Safety and Quality in Nursing Homes. The Commission provided the report to CMS on September 1, yet, two weeks later, Administrator Seema Verma has failed to release it. Administrator Verma’s refusal to immediately publicize the findings comes as reports allege communications officials at the Department of Health and Human Services have tampered with other information related to COVID-19, including the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report.
Issues:
September 13, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, reacted to more of President Trump’s executive orders today:
Issues:
September 8, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee and vocal advocate for safe, affordable, COVID-19 vaccines and treatments, joined a national press conference on shortages of COVID-19 treatment remdesivir with Dr. Tom Patterson, Chief of Infectious Diseases at UT Health San Antonio; Dr. Rochelle Walensky, Chief of Infectious Diseases at Massachusetts General Hospital; Zain Rizvi, Law and Policy Researcher at Public Citizen; and Joe Torsella, Pennsylvania Treasurer. This press call was held in coordination with The PrEP4All Collaboration, Public Citizen, and Social Security Works.
Issues:
August 31, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee and vocal advocate for science-led development of safe, affordable, COVID-19 vaccines and treatments, reacted to Food and Drug Administration (FDA) Commissioner Stephen Hahn telling the Financial Times that “his agency was prepared to authorise a vaccine before Phase Three clinical trials were complete,” raising concerns of political interference. Rep. Doggett’s statement:
Issues:
August 22, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), sponsor of the Delivering for America Act, released the following statement on its House passage a moment ago:
Issues:
August 20, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, joined with U.S. Representative Katie Porter (D-CA), a member of the House Committee on Oversight and Reform, to press the Trump Administration for answers on how HHS is protecting the taxpayer investment in funding and procurement agreements for Moderna’s COVID-19 vaccine.
Issues:
August 7, 2020
As the pandemic broadens and President Trump insists on rushing the short timeline for a COVID-19 vaccine, U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, joined with Representative Rosa DeLauro (D-CT), Chair of the Labor, Health and Human Services, and Education Appropriations Subcommittee, and eleven other members of Congress to press the Trump Administration for a comprehensive accounting and progress report on precisely how much taxpayer money has been poured into the COVID-19 vaccine efforts so far and how it is being used.
Issues:
August 6, 2020
U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, reacted to President Trump’s executive order on manufacturing today:
Issues:
August 5, 2020
Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chair of the House Ways and Means Health Subcommittee, reacted to the admission by Moderna today that “Moderna has not been living up to contractual obligations to disclose the percentage of taxpayer dollars that are funding its coronavirus vaccine project, but the pharmaceutical company tells Axios that federal money makes up ‘100% funding of the program.’” His statement:
Issues: